BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 16411197)

  • 1. Primary Pancreatic Lymphoma: Recommendations for Diagnosis and Management.
    Facchinelli D; Boninsegna E; Visco C; Tecchio C
    J Blood Med; 2021; 12():257-267. PubMed ID: 33981170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pancreatitis as the initial manifestation and abdominal lymph node enlargement in a boy].
    Fang YH; Peng KR; Chen FB; Tang LJ; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Oct; 20(10):844-847. PubMed ID: 30369361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3.
    Bozzoli V; Tisi MC; Pianese L; Tumini S; Rufini V; Calcagni ML; Pitocco D; Larghi A; Larocca LM; Massini G; Teofili L; D'Alò F; Hohaus S
    Mediterr J Hematol Infect Dis; 2012; 4(1):e2012005. PubMed ID: 22348187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation.
    Pearl-Yafe M; Yolcu ES; Yaniv I; Stein J; Shirwan H; Askenasy N
    Bioessays; 2006 Feb; 28(2):211-22. PubMed ID: 16435302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a microsatellite in FASL to type II diabetes and of the FAS-670G>A genotype to insulin resistance.
    Nolsøe RL; Hamid YH; Pociot F; Paulsen S; Andersen KM; Borch-Johnsen K; Drivsholm T; Hansen T; Pedersen O; Mandrup-Poulsen T
    Genes Immun; 2006 Jun; 7(4):316-21. PubMed ID: 16691186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurogenic mechanisms of development of type 1 diabetes mellitus].
    Savel'ev SV; Barabanov VM; Krivova IuS; Proshchina AE
    Arkh Patol; 2008; 70(6):9-13. PubMed ID: 19227273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary diabetes mellitus secondary to a primary pancreatic Burkitt lymphoma.
    Meier C; Kapellen T; Tröbs RB; Hirsch W; Parwaresch R; Kiess W; Körholz D
    Pediatr Blood Cancer; 2006 Jul; 47(1):94-6. PubMed ID: 16411197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms of pancreatic beta-cell destruction in type 1 diabetes].
    Isotani H; Hanafusa T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():383-7. PubMed ID: 12238077
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes.
    Sanlioglu AD; Griffith TS; Omer A; Dirice E; Sari R; Altunbas HA; Balci MK; Sanlioglu S
    J Cell Biochem; 2008 Jun; 104(3):710-20. PubMed ID: 18247339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex exocrine-endocrine relationship and secondary diabetes in exocrine pancreatic disorders.
    Chen N; Unnikrishnan I R; Anjana RM; Mohan V; Pitchumoni CS
    J Clin Gastroenterol; 2011; 45(10):850-61. PubMed ID: 21897283
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.